| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.33 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |